HIGHLIGHTS
- who: Unknown from the DREAM-CV Lab, McGill University Health Centre, McGill University, Canada have published the paper: Voice-Based Screening for SARS-CoV-2 Exposure in Cardiovascular Clinics (VOICE-COVID-19-II): Protocol for a Randomized Controlled Trial, in the Journal: (JOURNAL)
- what: Objective: This paper describes the study design of an open-label noninterventional crossover randomized controlled trial aimed at assessing whether interactive voice response systems can screen for SARS-CoV-2 in patients as accurately as standard screening done by people. The study aims to assess the concordance and interrater reliability of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.